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Exosomes are nano-sized extracellular vesicles, released from various cells, which can stimulate or repress
responses in targets cells. We recently reported that cultured cardiomyocytes are able to release exosomes and
that they, in turn, are involved in facilitating events in target cells by alteration of gene expression. We
investigated whether external stimuli of the cardiomyocyte might influence the transcriptional content of the
released exosomes.
Exosomes were isolated from media collected from cultured cardiomyocytes (HL-1) with or without growth
factor treatment (TGF-b2 and PDGF-BB), with a series of differential centrifugations, including preparative
ultracentrifugation and separation with a sucrose gradient. The exosomes were characterized with dynamic
light scattering (DLS), electron microscopy (EM) and Western blot and analyzedwith Illuminawhole genome
microarray gene expression.
The exosomes were rounded in shape and had an average size of 5090 nm in diameter with no difference
between treatment groups. Analysis of the mRNA content in repeated experiments conclusively revealed 505
transcripts in the control group, 562 in the TGF-b2-treated group and 300 in the PDGF-BB-treated group.
Common transcripts (217) were found in all 3 groups.
We show that the mode of stimulation of parental cells affects the characteristics of exosomes released.
Hence, there is a difference in mRNA content between exosomes derived from cultured cardiomyocytes
stimulated, or not stimulated, with growth factors. We also conclude that all exosomes contain a basic
package consisting of ribosomal transcripts and mRNAs coding for proteins with functions within the energy
supply system.
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E
xosomes are extracellular nano-sized vesicles, gen-
erated in multivesicular bodies (MVB) inside the
cell and released via exocytosis by the fusion of
MVB to the plasma membrane (1,2). They have pleio-
tropicfunctionssuchasantigenpresentation(3)andinter-
cellular transfer of proteins (4) and nucleic acids (57).
Accordingly, they are involved in cell-to-cell communica-
tion (8) and are released from a wide range of cells, for
example, T-cells (9), tumour cells (1012), mast cells
(13), prostatic acinar cells (14) and neuronal cells (15).
Exosomes from different cellular origins harbour a com-
mon set of molecules that are representative of their
biogenesis, structure and trafficking commission. In addi-
tion, they contain cell-type specific components that
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parental cell.
In 2007, Gupta et al. were the first to show that
cardiomyocytes release exosomes (16). They showed that
heat shock proteins released from the heart could be
found in cardiomyocyte exosomes. This finding opens
up a new field in cardiology where exosomes are pro-
posed as a new way of communication within the heart
and between other organs. We recently demonstrated that
cultured cardiomyocytes release exosomes containing
DNA and RNA and that they, in turn, are involved in
facilitating events in target cells by alteration of gene
expression (7).
To further investigate our finding, the cultured cardio-
myocytes were stimulated with growth factors and the
RNA content of the released exosomes were studied to
determine if the stimuli changed the RNA content or not,
thereby proposing that the external milieu is reflected
in differences in exosomal signalling. We have observed
in studies on rat that TGF-b2 (transforming growth
factor-b2) is highly involved in both chronic and acute
hypertrophy (17). TGF-b2 was therefore a natural choice
of growth factor. PDGF-BB (platelet-derived growth
factor BB) was chosen as it belongs to another family
of growth factors than TGF-b2 but has still been
associated with cardiac hypertrophy.
TGF-b2 is a pleiotropic cytokine, meaning that it has
an effect on many different types of cells, and is a member
of the transforming growth factor family. TGF-b2 is also
required for valve remodelling during cardiac develop-
ment (18) and it has been demonstrated that TGF-b2
enhances the differentiation of cardiomyocytes from em-
bryonic stem cells (19). In cardiac hypertrophy, TGF-
b2 regulates cardiac remodelling (20) and alters the
gene expression and thereby promotes the foetal gene
programme (21).
Cardiomyocytes express 2 types of PDGF receptors
to which PDGF-BB has affinity. PDGF-BB is known to
promote hypertrophy and an anti-apoptotic effect in
target cells (22,23), and the expression of PDGF-BB
rises as a response to stress and pressure overload (24).
In this study, we treated cultured cardiomyocytes with
TGF-b2 and PDGF-BB, to study if the characteristics of
theexosomes,including theirpossiblemessenger function,
are affected by the external milieu of the cardiomyocytes.
Materials and methods
Cell culture
HL-1 is a cell line derived from adult mouse heart,
displaying phenotypic features typical of adult cardio-
myocytes (25). This cell line was acquired from Dr. W.C.
Claycomb (Louisiana State University Medical Center,
New Orleans, LA). Cardiomyocytes were grown in T-75
culture flasks coated with fibronectin (Sigma-Aldrich)-
gelatin (Fisher Scientific) and maintained in Claycomb
Medium (JRH. Biosciences) supplemented with ultracen-
trifuged 10% foetal bovine serum (JRH. Biosciences),
0.1 mM norepinephrine (Sigma-Aldrich) (in a solution
of 30 mM ascorbic acid), 2 mM L-glutamine (Life
Technologies), 100 U/mL penicillin and 100 mg/mL
streptomycin (Life Technologies). During culture, the
medium was changed every 24 h. The cells were passaged
at confluence (approximately every third day) by trypsini-
zation (Trypsin- EDTA, Life Technologies). All culture
flasks were kept in an atmosphere of 95% air to 5% CO2,
378C and at a relative humidity of approximately 95%.
Pre-treatment of cells
In the treatment groups, the cells were stimulated with
either TGF-b2 (10 ng/mL) and PDGF-BB (100 ng/
mL; Biosource, Invitrogen) dissolved in serum-free and
antibiotic-free media. Flasks with no growth factor
addition were used as controls. After 23 h, the medium
from each growth condition was collected and frozen
before exosome isolation.
Cell harvest
Cells were harvested with trypsin, after collection of the
cellculturemedia,andwashedtwicewithPBS(phosphate-
buffered saline). They were again suspended in PBS and
storedat 808C.Afterlysationofthecellsuspensionwith
alysisbuffer,theproteinconcentrationwasmeasuredwith
a BCA protein assay kit (Pierce Protein Biology Products,
Rockford, IL, USA).
Exosome isolation
Differential centrifugations were carried out of the col-
lected cell culture media to obtain exosomes; centrifuga-
tion for 30 min at 2,000g and 35 min at 10,000g, after
which the supernatant was filtered through a 0.22-mm
filter. The exosomes were then pelleted by ultracentrifu-
gation of the filtrate at 110,000g for 2 h. Pellets were
re-suspended in PBS. A sucrose gradient was prepared by
10 mL each of 40 and 20% sucrose, respectively. One mL
of resuspended exosomes was loaded onto the top of the
gradient, followed by immediate ultracentrifugation at
110,000g for 2 h. After centrifugation, 2 mL fractions
were collected from the band of the gradient. The frac-
tions were washed with PBS and ultracentrifuged at
110,000g for 2 h. The pellets were resuspended in
PBS. All ultracentrifugations were performed using the
L-90 Beckman centrifuge (Beckman Instruments, Inc.,
Fullerton, CA) and the SW-41 rotor (Beckman Instru-
ments, Inc., Fullerton, CA) at 48C.
Western blot
Following lysation of isolated exosomes from 10 T75
culture flasks/group and cells with a lysis buffer, the
protein concentration was measured with a BCA protein
assay kit (Pierce Protein Biology Products, Rockford, IL)
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in the analysis. The lysates of the exosome samples and
the cell suspension were separated by 10% SDS-PAGE.
Protein was transferred to a polyvinylidene difluoride
membrane using a Bio-Rad Mini Transblot electrophore-
tic transfer cell, according to the manufacturer’s pro-
tocol. The blot was blocked with 5% bovine serum
albumin (BSA) in Tris-buffered saline (TBS) containing
0.1% (v/v) Tween 20 (TBST). Mouse monoclonal anti-
TSG101 (abcam, UK), rabbit polyclonal anti-GRP78
(abcam, UK) and mouse monocolonal anti-CD63 (BD
Pharmingen, USA) were used as primary antibodies in
the different experiments according to the manufacturer’s
protocols. CD63 (a tetraspanin) is a common exosome
marker (26), TSG101 (tumour susceptibility gene protein
101) is another exosome marker that is also present in
cell suspension (26) and GRP78, a member of the heat
shock protein family of molecular chaperons, is a protein
associated with the endoplasmatic reticulum and cellular
stress and found in apoptotic bodies (27). Polyclonal
rabbit anti-mouse or anti-rabbit IgG-horseradish peroxi-
dase (HRP) secondary antibodies (Dako, Denmark) were
added for 1 h. After extensive washes with TBS, spots
were detected using ECL Advance Western Blotting
Detection Kit (GE Healthcare Life sciences, UK). All
Western blot experimental results were scanned using
Molecular Imager† GelDoc
TM (Biorad, CA).
Dynamic light scattering size analysis of the
exosomes
The exosome size/diameter was estimated by dynamic
light scattering (DLS). The mean hydrodynamic diameter
of exosomes was calculated by fitting a Gaussian function
to the measured size distribution.
Prior to the DLS measurements, each exosome sample
(4 controls, 4 TGF-b2 and 3 PDGF-BB-treated samples,
the same samples used in the microarray analysis) was
shaken at 48C for 20 min to dissolve possible exosome
aggregates. About 50 mL of each sample was added to a
cuvette with a 10 mm path length. DLS measurements
were conducted at 208C using a Nano Zetasizer (Malvern
Instruments Ltd., UK) operating at 633 nm and record-
ing the back scattered light at an angle of 1738. The
sample temperature was allowed to equilibrate for 10 min
before each measurement. The light scattering was
recorded for 200 s with 10 replicate measurements. DLS
signal intensity was transformed to volume distribution
[volume (%)], assuming a spherical shape of the exo-
somes, using the Dispersion Technology Software v.5.10
(Malvern Instruments Ltd., UK). The peak maximum
of the Gaussian function was used to estimate exosome
size. Gaussian fitting, mean value and standard deviation
were calculated and compared using OriginPro 9.0.0
(OriginLab Corp, USA). Peak maximum of the Gaussian
function was used to estimate exosome size. Outliers were
detected and rejected by calculation of the Dixon’s Q
ratio, using p0.05 (28).
Electron microscopy
One pooled sample of exosomes, including isolated
exosomes from 10 T75 culture flasks from each exosome
group, that is, control, TGF-b2 treated and PDGF-BB
treated, were, after isolation, washed 2 extra times with
PBS at 110,000g for 2 h to remove excess sucrose.
Exosomes were then resuspended in 10 mM Tris-HCl
buffer (pH 7.4) with 10 mM MgCl2, after which 4 mLo f
the suspension was allowed to adhere to Formvar-coated
grids for 3 min at room temperature. The samples were
negatively stained with 1% sodiumsilicotungstate. The
sample grids were examined in a JEOL 1,230 TEM
(JEOL Scandinavia local office, Sollentuna, Sweden) and
digital images were captured by using a Gatan MSC
600CW (Gatan Inc., Abingdon, UK).
RNA preparation
Foreach exosomesample (1 T75 cultureflask), total RNA
wasisolated using the RNeasy Fibrous Tissue Kit (Qiagen
AB Nordic, Sollentuna, Sweden). The concentrations
of the RNA were measured in a NanoDrop ND-
1,000 Spectrophotometer (NanoDrop Technologies Inc.,
Wilmington, DE). The integrity of the RNAwas analyzed
with a 2,100 Bioanalyser (Agilent Technologies Inc., Palo
Alto, CA).
Total RNA was also isolated from the corresponding
parental cells of each exosome sample. This was also done
using the RNeasy Fibrous Tissue Kit (Qiagen AB Nordic,
Sollentuna, Sweden). The concentration of the RNA was
measured in a NanoDrop ND-1,000 Spectrophotometer
(NanoDrop Technologies Inc., Wilmington, DE).
Fig. 1. Western blots results. CD63 is present in all 3 of the
exosome samples but not in the cell suspension, while Tsg101 is
enriched in both the exosome samples and the cell suspension.
Grp78 is only found in the cell suspension, indicating no
detectable contamination of apoptotic bodies. These results
demonstrate the authenticity of the exosome samples.
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TheIlluminaTotalprepRNAAmplificationKit(Ambion,
Carlsbad, CA) was used to convert aliquots of total
RNA to biotinylated double-stranded cRNA for both
theexosomeRNAsamplesandthecorrespondingparental
cell RNA samples. The biotinylated cRNA samples were
hybridized to MouseRef-8 Expression Beadchip (Illumina
Inc.,SanDiego,CA),incubatedwithstreptavidin-Cy3and
scanned using the Illumina Beadstation GX, analyzing
18,139 gene transcripts. Four samples in each exosome
groupand4samplesineachcorrespondingcellgroupwere
analyzed. Each sample consisted of exosomes or cells
Fig. 2. Dynamic light scattering, size determining results. DLS measurements of exosomes released from cells after 23 h incubation of
controls (A), cells stimulated with TGF-b2 (B) and cells stimulated with PDGF-BB (C). The DLS showed an average size between 57.3,
57.8 and 62.3 nm for controls, TGF-b2- and PDGF-BB-treated samples, respectively (D). No signiﬁcant intergroup differences are seen
between the groups. A peak corresponding to a hydrodynamic radius of approximately 1 nm was seen in some samples (B and C), which
is most likely a contamination of residual sucrose left after the sucrose gradient centrifugation. Larger elements, over 100 nm in size,
were also observed (AC). Such elements are probably aggregates of exosomes also present in the electron microscopy analysis.
Fig. 3. Electron microscopy of puriﬁed exosomes. The exosomes are rounded and surrounded by a lipid bilayer. They have a somewhat
electron dense content displaying a similar size of approximately 5090 nm in diameter in all 3 treatment groups. A) Example of an
exosome in the control group. B) Example of 2 exosomes in the TGF-b2-treated group. C) Example of an exosome in the PDGF-BB-
treated group. All 3 exosome groups contained exosomes with different densities. Shown in the ﬁgure are the best pictures of exosomes
from each group that happened to be of different density, but this does not indicate that there were any differences between the groups
when taking all exosomes into account.
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from 4 different culture flasks/experiments in each exo-
some orcell group. The data from theexosomemicroarray
have the GSE40503 accession number in the gene expres-
sion omnibus (GEO) and the corresponding cell data
have the GSE45207 accession number. The significant
transcript can also be found in Vesiclepedia (29).
Data analysis of gene expression microarrays
To detect exosome mRNA content, microarray data were
analyzed using the gene expression module in Illumina
Beadstudio software, version 3.3.7.
In each exosome group (control, TGF-b2- and PDGF-
BB-treated), 4 samples were analyzed. Intensity data were
normalized using the Beadstudio cubic spline algorithm.
Detection p-value B0.01 was used to filter which gene
transcripts that had significantly detected signals on the
microarrays and therefore represented mRNA assignable
to the exosomes.
In each corresponding cell group (control, TGF-b2-
and PDGF-BB-treated), 4 samples were analyzed. In-
tensity data were also normalized using the Beadstudio
cubic spline algorithm. Detection p-value B0.05 and a
signal intensity  30 were used to filter which gene
transcripts that had significantly detected signals on the
microarrays and therefore represented mRNA assignable
to the cells.
MetaCore
TM (GeneGo Inc., USA) was used to find
common transcriptional relations between the growth
factor added to the cardiomyocytes and the transcripts
found in the derived exosomes and this was done with a
direct interaction network. Significant transcripts speci-
fically found in the 2 exosome groups derived from
growth factor stimulated cardiomyocytes were included
in this analysis. These transcripts were not found in the
control exosome group.
Results
Western blot
CD63 was recognized in exosomes of the control group as
well as in the 2 treatment groups, but not in the cell
suspension, indicating that exosomes had been success-
fully purified (Fig. 1). TSG101 was found both in the
exosome samples and the cell suspension (Fig. 1). GRP78
was only found in the cell suspension and not in the
exosome samples (Fig. 1), indicating no detectable con-
tamination of apoptotic bodies. No sensitivity problems
with antibodies used were apparent.
Dynamic light scattering size analysis of the
exosomes
The DLS measurement showed an average exosome size
between 57 and 72 nm in diameter after 23 h incubation,
with no intergroup differences (control and the 2 treat-
mentgroups)(Fig. 2).Apeakcorresponding toa diameter
of approximately 1 nm was also seen in some samples
(Fig. 2B and C). This is most likely a contamination of
residual sucrose left after the sucrose gradient centrifuga-
tion. Larger elements, over 100 nm in size, were present
(Fig. 2AC). Such elements might be aggregates of
exosomes also observed in the EM analysis.
Electron microscopy
EM analysis of the isolated exosomes revealed the
presence of vesicles with a characteristic rounded shape
and with a diameter ranging from 40 to 90 nm (Fig. 3
AC). No differences in size or appearance were found
between the control exosomes and the exosomes derived
from growth factor treated cardiomyocytes (Fig. 3AC).
All 3 exosome groups consisted of exosomes with varying
electron densities. Large aggregates of exosomes were
occasionally found.
Microarray gene expression
The Bioanalyzer analysis showed no signs of ribosomal
18S or 28S peaks, indicating that the mRNA present has
originated from the exosomes and not from cell suspen-
sion or debris. One sample was excluded from the PDGF-
BB group since it was recognized as an outlier due to
poor hybridization and labelling.
Fig. 4. Venn diagram of microarray results. Overlapping circles
demonstrating the number of gene transcripts in common, par-
tially in common or unique to each speciﬁc exosome treatment
group. Of the signiﬁcant transcripts, 217 were common for all
3 treatment groups, 88 were unique for the control exosomes,
145 unique for the TGF-b2 exosomes and 39 unique for the
PDGF-BB exosomes. The control group and TGF-b2-treated
group shared 178 transcripts, the TGF-b2-treated group and
PDGF-BB-treated group shared 22 transcripts and the PDGF-
BB-treated group and control group shared 22 transcripts. Red
circle: control exosomes, green circle: TGF-b2-derived exosomes
and blue circle: PDGF-BB-derived exosomes.
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The gene transcripts with a detection p-value B0.01 (**)
were defined as significant. However, for the transcript to
be confirmed as present in the exosomes, the transcript
also had to be found significant (detection p-value B0.05
and signal intensity  30) in the corresponding cell group.
With these settings, 505 transcripts were found in all
samples of the control group (n4), 562 transcripts in all
samples of the TGF-b2-treated group (n4) and 300
in all samples of the PDGF-BB-treated group (n3)
(Supplemental Table 1). Of these transcripts, 217 were
common for the 3 groups, 88 were unique for the control
exosomes, 145 unique for the TGF-b2 exosomes and 39
unique for the PDGF-BB exosomes (Fig. 4, Supplemental
Table 1). The control group and TGF-b2-treated group
shared 178 transcripts, the TGF-b2-treated group and
PDGF-BB-treated group shared 22 transcripts and the
PDGF-BB-treated group and control group shared 22
transcripts (Fig. 4, Supplemental Table 1).
Examples of unique transcripts in the TGF-b2-treated
group were NFAT5 and HDAC5.
In the common group of transcripts, found in all 3
exosome treatment groups, about 13% were unknown
loci, about 15% were ribosomal mRNAs and about
5% were connected to the energy supply system and the
mitochondria.
The MetaCore direct interaction network analysis
of transcripts specifically found in the exosomes derived
from growth factor treated cardiomyocytes revealed that
61 (36.5%) of the transcripts found in the TGF-b2
exosomes and 29 (47.5%) of the transcripts found in the
PDGF BB exosomes could be explained as a direct result
of the added growth factor. A number of transcription
factors were identified to possibly be responsible for the
transcription of several of the transcripts specifically
found in the exosomes derived from the growth factor
stimulated cardiomyocytes (Fig. 5). In the TGF-b2-
treated group octamer-binding transcription factor
Fig. 5. Growth factor signalling explaining the presence of transcripts in the growth-factor-derived exosomes. Analyzing all gene
transcripts uniquely found in the growth factor groups with GeneGo MetaCore direct interaction network analysis indicated that the
presence of 47.5% of the transcripts found in the TGF-b2-derived exosomes and 36.5% of the transcripts in the PDGF-BB-derived
exosomes could be the result of a downstream transcription induced by the growth factor stimulation. Oct-3/4, octamer-binding
transcription factor 3/4; ESR1, oestrogen receptor 1; AP-1, activator protein 1; SP1, speciﬁcity protein 1; c-Myc, myc proto-oncogene
protein; Elk1, E twenty-six (ETS)-like transcription factor 1.
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protein 1 (AP-1), specificity protein 1 (SP1) and myc
proto-oncogene protein (c-Myc) were most prominent
(Fig. 5). In the PDGF-BB-treated group, E twenty-six
(ETS)-like transcription factor 1 (Elk1), AP-1, SP1 and
c-Myc were most prominent (Fig. 4).
Discussion
The main finding of the present study wasthe unequivocal
response of cultured cardiomyocytes to the stimulation
with 2 different growth factors in terms of transcriptional
contents of secreted exosomes. Furthermore, different
growth factors induce individual responses.
All gene expression analyses were performed on 4
different samples in each exosome treatment group.
Although 1 PDGF-BB exosome sample was considered
an outlier and was removed, the number of samples used
strengthens the validity of the gene transcripts found in
each exosome treatment group. The corresponding cell
sample to the outlier in the PDGF-BB exosome group
was also an outlier in the microarray analysis of the
cellular transcripts.
In the common pool of transcripts, found in all 3
groups (TGF-b2-treated, PDGF-BB-treated and con-
trols), almost 15% of the transcripts were ribosomal and
5% were connected to the energy supply system, which
was also seen in our previous characterization study (7).
This basic transcriptional package would include struc-
tural ribosomal mRNA as well as transcripts coding for
proteins involved in the generation of energy in the target
cell. One of the characteristics of cardiomyocytes is that
they contain a large number of mitochondria, due to the
high, constant energy demand. Another feature of the
cardiomyocyte is the high turnover of proteins, which
could explain the ribosomal mRNA content.
Apart from the common pool of 217 transcripts, there
was a group of specific transcripts uniquely found in the
control exosomes (88 transcripts), containing a variety of
mRNAs with different functions and protein products.
Together, these groups would represent the habitual
cardiomyocyte state and include transcripts coding for
proteins involved in intracellular transport, MAPK-
signalling pathways and the nucleus.
The MetaCore direct interaction network analysis
indicated that the presence of 36.5% of the transcripts
found in the TGF-b2-derived exosomes and 47.5% of the
transcripts in the PDGF-BB-derived exosomes could be
the result of a downstream transcription induced by the
growth factor stimulation.
In the specific group of transcripts for the TGF-b2
group (145 transcripts), nuclear factor of activated T-cells
5 (NFAT5) was found. NFAT5 is involved in cellular
proliferation and NFAT5 mRNA expression is particu-
larly high in proliferating cells (30). NFAT5 is a transcrip-
tion factor that stimulates the expression of hypertrophic
genes together with other transcription factors, such as
GATA4 and activating protein-1 (31). This result indi-
cates that TGF-b2 affects the exosome content in
mediating both a proliferation and hypertrophy signal.
Furthermore, in the group of transcripts that were
common for both growth factors (22 transcripts), histone
deacetylase 5 (HDAC5) was found. HDAC5 is known to
regulate the differentiation of mesodermal cells into
cardiac muscle cells (32) but also as a transcriptional
regulator repressing the expression of hypertrophic genes
(33). This finding, of a signal of both an anti-hypertrophic
and a differentiation nature, might indicate that pro-
liferation and cardiac development are favoured before
hypertrophic progression in the cell culture, since the
cardiomyocytes are proliferating at a high rate in a
cultured state.
Conclusion
To conclude, cardiomyocytes-released exosomes contain
a basic package of transcripts common for exosomes
derived from unstimulated as well as growth factor
stimulated cardiomyocytes. In addition, the growth factor
treatment of the cardiomyocytes seems to alter the
exosome transcriptional content, mediating signals for
proliferation, development and hypertrophy. Accordingly,
we conclude that there is a difference in exosomal content
between control exosomes and exosomes derived from
growth factor stimulated cardiomyocytes.
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